GlassScriptPhysician profile
Omar K Khalique
NPI 1629376850
$118,836.01
in general payments reported to CMS, 2019-2025
19 companies · $43K in 2025
The $43K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,902 · 2020: $8,665 · 2021: $2,940 · 2022: $4,560 · 2023: $39K · 2024: $14K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Consulting Fee: $26K · Food and Beverage: $4,943 · Education: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $37,758.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,192.50 |
| Consulting Fee | $25,624.94 |
| Food and Beverage | $4,942.81 |
| Education | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $40,938.76 | 2022-2025 | Acuson Origin Diagnostic Ultrasound System, Naeotom Alpha, Somatom Pro.Pulse |
| Novo Nordisk As | $32,423.18 | 2023 | |
| Heartflow, INC. | $16,840.79 | 2019-2025 | Ffrct |
| Edwards Lifesciences Corporation | $7,866.13 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $7,081.11 | 2019-2025 | Mitraclip, Triclip, Navitor |
| Boston Scientific Corporation | $5,024.94 | 2020-2024 | Watchman |
| Jenavalve Technology, INC. | $3,589.88 | 2019-2024 | Jenavalve Pericardial Tavr System |
| Philips North America LLC | $3,451.63 | 2022-2025 | Igt Devices Undivided |
| Biosense Webster, INC. | $586.39 | 2024 | Carto 3 |
| Medtronic, INC. | $358.16 | 2024-2025 | Symplicity G3, Corevalve Evolut R |
| Ge Healthcare | $269.58 | 2024-2025 | |
| Digirad Health, INC | $110.12 | 2025 | Cardius |
| Recor Medical INC | $107.89 | 2025 | Paradise Ultrasound Renal Denervation System |
| Canon Medical Systems USA, INC. | $67.51 | 2019 | |
| Amgen INC. | $38.52 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cleerly, INC. | $26.42 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.87 | 2025 | Lifevest |
| Cumberland Pharmaceuticals, INC. | $19.13 | 2024 | Caldolor |
| Morphosys, US INC. | $15.00 | 2023 | Monjuvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Khalique listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.